Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb;11(2):311-317.
doi: 10.21037/tp-21-460.

A novel de novo TBX20 variant in a 6-year-old Chinese girl with left ventricular noncompaction: a case report

Affiliations
Case Reports

A novel de novo TBX20 variant in a 6-year-old Chinese girl with left ventricular noncompaction: a case report

Meng-Ying Zuo et al. Transl Pediatr. 2022 Feb.

Abstract

Left ventricular noncompaction (LVNC) is a particular type of cardiomyopathy with an excessively prominent trabecular meshwork and deep intertrabecular recesses in the left ventricle (LV). The clinical manifestation of LVNC is highly variable, ranging from no symptom to congestive heart failure, arrhythmia, thrombosis, and potentially sudden cardiac death. Approximately half of LVNC cases are hereditary. TBX20 is expressed in human embryonic and vertebrate hearts. In this article, we report on a case of pediatric LVNC with a novel de novo TBX20 [c.859C>T, p.(Arg287Trp)] gene variant, which appears to be pathogenic and had not been previously reported in LVNC. The 6-year-old girl was admitted to our hospital for unexplained syncope. 2D-echocardiography revealed a dilated LV with numerous prominent trabeculations, and a two-layered structure, comprising a compacted thin epicardial band and a thicker non-compacted endocardial layer, with deep endomyocardial spaces and intertrabecular recesses in LV. During the follow-up, the child has not shown any obvious clinical signs or symptoms. In this case report, the de novo variant of TBX20 in LVNC expands the spectrum of variants that cause LVNC and contributes to the genetic counseling and individualized treatment of patients. Clinicians should focus on exploring the clinical and genetic characteristics of LVNC to provide therapies and follow-up to improve the outcome.

Keywords: TBX20; case report; exome sequencing (ES); left ventricular noncompaction (LVNC).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-21-460/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Echocardiographic examination of the proband. (A,B) Echocardiography revealed a dilated LV (indicated by the red arrows) and LA; (C) a two-layered structure with a compacted thin epicardial band, a thicker non-compacted endocardial layer and prominent trabeculations in the lower and middle LV (indicated by the red arrows). LV, left ventricle; LA, left atrium; RV, right ventricle; RA, right atrium.
Figure 2
Figure 2
CMR examination of the proband. (A) Some prominent trabeculations and deep perfused intertrabecular recesses were seen in the LV apex and lateral wall (indicated by the red arrows); (B) a compacted thin epicardial band and a thicker non-compacted endocardial layer in the systolic. The short red line illustrates a compacted thin epicardial band and the long red line illustrates a thicker non-compacted endocardial layer. CMR, cardiac magnetic resonance; LV, left ventricle.
Figure 3
Figure 3
The ECG showed T-wave morphology changes in several leads (III, V1, V3, indicated by the red arrows). ECG, electrocardiograph.
Figure 4
Figure 4
A heterozygous variant of the TBX20 gene (c.859C>T, p.R287W) was identified in the proband. Sanger sequencing failed to detect this variant in her parents (indicated by the red arrows).

Similar articles

References

    1. Arbustini E, Weidemann F, Hall JL. Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases? J Am Coll Cardiol 2014;64:1840-50. 10.1016/j.jacc.2014.08.030 - DOI - PMC - PubMed
    1. Sedaghat-Hamedani F, Haas J, Zhu F, et al. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy. Eur Heart J 2017;38:3449-60. 10.1093/eurheartj/ehx545 - DOI - PubMed
    1. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006;113:1807-16. 10.1161/CIRCULATIONAHA.106.174287 - DOI - PubMed
    1. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24. 10.1038/gim.2015.30 - DOI - PMC - PubMed
    1. Jenni R, Oechslin E, Schneider J, et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001;86:666-71. 10.1136/heart.86.6.666 - DOI - PMC - PubMed

Publication types